Literature DB >> 1318173

Differential development of beta-endorphin and mu opioid binding sites in mouse brain.

J Barg1, R A Rius, W T Bem, M M Belcheva, Y P Loh, C J Coscia.   

Abstract

Mouse brains of various ages from embryonal day 14 (E14) to adult were analyzed for opioid receptor binding using the enkephalin analog Tyr-D-Ala-Gly-NMe-Phe-Gly-ol (DAMGE) and the opiate alkaloid dihydromorphine (DHM) as mu-selective radioligands. Binding parameters were estimated from homologous and heterologous competition binding curves. During the postnatal period, Kd values for [3H]DAMGE did not change but Bmax values (fmol/mg protein) increased 2.7 fold from postnatal day 3 (P3) to P7. Minor receptor density fluctuations were evident from P7 to adult. Similar results were obtained with [3H]DHM. In contrast, estimation of total mu binding sites (fmol/brain) revealed a continuous rise from P3 to the adult. The postnatal developmental profile of total mu binding sites was comparable to the weight gain of mouse brain and the increase in protein content. In contrast, during the same period beta-endorphin immunoreactivity (IR) levels undergo an increase that is inversely proportional to mu opioid receptor Bmax values. [3H]DAMGE binding to E14 membrane preparations was inhibited to a greater extent by Gpp(NH)p than that to P1 or adult. Additional characterization of mu receptors was accomplished by heterologous competition binding assays. IC50 values for beta-endorphin in competition with [3H]DHM and [3H]DAMGE were age dependent and differed for the two radioligands. These results suggest that mu receptor selectivity for mu-specific peptide and alkaloid ligands changes as a function of age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318173     DOI: 10.1016/0165-3806(92)90142-j

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  6 in total

1.  A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice.

Authors:  P E Lutz; D Reiss; A M Ouagazzal; B L Kieffer
Journal:  Behav Brain Res       Date:  2013-01-04       Impact factor: 3.332

2.  Dynorphins modulate DNA synthesis in fetal brain cell aggregates.

Authors:  A Gorodinsky; J Barg; M M Belcheva; R Levy; R J McHale; Z Vogel; C J Coscia
Journal:  J Neurochem       Date:  1995-10       Impact factor: 5.372

Review 3.  Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients.

Authors:  B J Anderson; A D McKee; N H Holford
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

4.  Beta-endorphin is a potent inhibitor of thymidine incorporation into DNA via mu- and kappa-opioid receptors in fetal rat brain cell aggregates in culture.

Authors:  J Barg; M Belcheva; R McHale; R Levy; Z Vogel; C J Coscia
Journal:  J Neurochem       Date:  1993-02       Impact factor: 5.372

5.  Glucocorticoids modulate the biosynthesis and processing of prothyrotropin releasing-hormone (proTRH).

Authors:  T O Bruhn; S S Huang; C Vaslet; E A Nillni
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

6.  The effects of aging on hydromorphone-induced thermal antinociception in healthy female cats.

Authors:  Bradley T Simon; Elizabeth M Scallan; Beatriz P Monteiro; Paulo V M Steagall
Journal:  Pain Rep       Date:  2019-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.